MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Current portion ofdeferred consideration,...$148K Prepaid expenses andother current assets$3,351K Inventories, net$3,703K Accounts receivable, net$2,382K Cash and cashequivalents$2,561K Other assets$64K Deferred tax asset, net$458K Operating lease, right ofuse assets$642K Property and equipment,net$314K Total current assets$12,145K Total assets$13,623K Total liabilities andstockholders equity$13,623K Total stockholdersequity$3,432K Total liabilities$10,191K Accumulated othercomprehensive loss-$3,191K Accumulated deficit-$200,400K Additional paid-in capital$207,023K Operating leaseliabilities, less current...$509K Withholding tax payable$5,465K Total currentliabilities$4,217K Operating leaseliabilities, current portion$146K Deferred revenue,current portion$314K Accrued expenses andother current...$2,111K Accounts payable$1,646K
Balance Sheet
source: myfinsight.com

Sonoma Pharmaceuticals, Inc. (SNOA)

Sonoma Pharmaceuticals, Inc. (SNOA)